Innate Pharma (IPHA) Institutional Ownership $1.64 -0.06 (-3.53%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Innate Pharma (NASDAQ:IPHA)CurrentInstitutional OwnershipPercentage0.16%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$33.29KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$489.39K Get IPHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Innate Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPHA Institutional Buying and Selling by Quarter Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Innate Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/10/2024 Exchange Traded Concepts LLC77,350$177K0.0%-10.3%0.096% 2/13/2024 Optiver Holding B.V.22,705$64K0.0%-88.1%0.028% 1/5/2024 Exchange Traded Concepts LLC46,888$131K0.0%+34.0%0.058% 11/13/2023 Optiver Holding B.V.190,219$481K0.0%+132.6%0.236% 10/18/2023 Exchange Traded Concepts LLC34,998$89K0.0%-17.5%0.043% 8/10/2023 Optiver Holding B.V.81,796$257K0.0%-63.5%0.102% 7/20/2023 Exchange Traded Concepts LLC42,431$133K0.0%N/A0.053% 5/11/2023 Optiver Holding B.V.224,097$636K0.0%+112.3%0.279% 2/14/2023 Susquehanna International Group LLP13,315$50K0.0%N/A0.017% 2/10/2023 Optiver Holding B.V.105,534$394K0.0%-43.1%0.132% 8/10/2022 Optiver Holding B.V.181,944$491K0.0%+366.8%0.228% 2/9/2022 Alps Advisors Inc.93,718$429K0.0%N/A0.118% 12/1/2021 Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/16/2021 Two Sigma Securities LLC17,119$106K0.0%N/A0.022% 11/15/2021 Pura Vida Investments LLC82,509$509K0.0%N/A0.104% 11/15/2021 Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/12/2021 Affinity Asset Advisors LLC125,000$771K0.2%N/A0.158% 5/21/2021 Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/20/2021 Optiver Holding B.V.30,284$131K0.0%N/A0.038% 5/18/2021 Millennium Management LLC49,734$214K0.0%-9.1%0.063% 5/18/2021 Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/14/2021 Optiver Holding B.V.55,588$240K0.0%N/A0.070% (Data available from 1/1/2016 forward) IPHA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPHA shares? During the previous two years, the following institutional investors and hedge funds held shares of Innate Pharma shares: Exchange Traded Concepts LLC ($177K), and Optiver Holding B.V. ($64K), Susquehanna International Group LLP ($50K).Learn more on IPHA's institutional investors. What percentage of Innate Pharma stock is owned by institutional investors? 0.16% of Innate Pharma stock is owned by institutional investors. Learn more on IPHA's institutional investor holdings. Which institutional investors have been buying Innate Pharma stock? The following institutional investors have purchased Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($226.99K), Exchange Traded Concepts LLC ($54.32K), and Susquehanna International Group LLP ($13.32K). How much institutional buying is happening at Innate Pharma? Institutional investors have bought a total of 294,622 shares in the last 24 months. This purchase volume represents approximately $825.65K in transactions. Which Innate Pharma major shareholders have been selling company stock? The following institutional investors have sold Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($389.59K), and Exchange Traded Concepts LLC ($16.32K). How much institutional selling is happening at Innate Pharma? Institutional investors have sold a total of 405,911 shares in the last 24 months. This volume of shares sold represents approximately $1.24M in transactions. Related Companies PROK Major Shareholders GHRS Major Shareholders ZVRA Major Shareholders ESPR Major Shareholders TERN Major Shareholders KRRO Major Shareholders MGTX Major Shareholders ARCT Major Shareholders RGNX Major Shareholders XERS Major Shareholders This page (NASDAQ:IPHA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
